摘要:
Novel acrylic amide derivative of the formula wherein R¹ represents a hydrogen or a halogen atom or a C₁₋₄alkyl, a C₁₋₄alkoxy or a nitro group. n is an integer of 0 to 2, A represents an amino acid residue derived from a naturally occuring amino acid or an antipode thereof which is connected to the acrylic acyl residue through its amino group; or a residue derived from thiazolidinecarboxylic acid connected to the acrylic acyl group through its nitrogen, or a derivative of the above residues wherein any free carboxy group is esterified with a C₁₋₄alkyl group or is amidated; or A represents a group of formula wherein R₂ is a hydrogen atom or a phenyl, a C₁₋₄alkyl or a C₁₋₄alkoxycarbonyl group, and their salts which have interesting cytoprotective and antiulcer activities are provided. A process is also described for the preparation of said compounds.
摘要:
Novel acrylic amide derivative of the formula wherein R¹ represents a hydrogen or a halogen atom or a C₁₋₄alkyl, a C₁₋₄alkoxy or a nitro group. n is an integer of 0 to 2, A represents an amino acid residue derived from a naturally occuring amino acid or an antipode thereof which is connected to the acrylic acyl residue through its amino group; or a residue derived from thiazolidinecarboxylic acid connected to the acrylic acyl group through its nitrogen, or a derivative of the above residues wherein any free carboxy group is esterified with a C₁₋₄alkyl group or is amidated; or A represents a group of formula wherein R₂ is a hydrogen atom or a phenyl, a C₁₋₄alkyl or a C₁₋₄alkoxycarbonyl group, and their salts which have interesting cytoprotective and antiulcer activities are provided. A process is also described for the preparation of said compounds.
摘要:
Compounds of the general formula (I), wherein R is hydrogen, halogen, C₁₋₄alkyl, C₁₋₄alkoxy or C₁₋₄acylamino group; R₁ is hydrogen or a carboxyl-protective group; and R₂ represents a -(CH₂) n -CO₂R₅ group, wherein n is 1, 2, 3 or 4; and R₅ is hydrogen or a carboxyl-protective group; or R₂ is a -(CH₂) n -NH₂ group, wherein n is 1, 2, 3 or 4 in the E and/or Z configuration, as well as their salts, show a cytoprotective effect and promote the healing of stomach ulcers. Their toxicity is low.
摘要:
Compounds of the general formula (I), wherein R is hydrogen, halogen, C₁₋₄alkyl, C₁₋₄alkoxy or C₁₋₄acylamino group; R₁ is hydrogen or a carboxyl-protective group; and R₂ represents a -(CH₂) n -CO₂R₅ group, wherein n is 1, 2, 3 or 4; and R₅ is hydrogen or a carboxyl-protective group; or R₂ is a -(CH₂) n -NH₂ group, wherein n is 1, 2, 3 or 4 in the E and/or Z configuration, as well as their salts, show a cytoprotective effect and promote the healing of stomach ulcers. Their toxicity is low.
摘要:
Known acrylic acid derivatives of formula wherein n is an integer of from 0 to 2, R represents a hydrogen, an alkaline or an alkaline earth metal atom, or a C₁₋₄alkyl-group, and R¹ represents a hydrogen or a halogen atom or a C₁₋₄-alkyl, a C₁₋₄alkoxy or a nitro group have useful pharmaceutical activities, in particular cytoprotective and optionally antiulcer activities. They can be used in the treatment and prevention of ulceration in the digestive tract of mammals, inclusive men.
摘要:
The present invention relates to a compound of formula (I) wherein R' represents methyl or a group of the formula R 3 -NH-/CH 2 ) 4 - wherein R 3 is hydrogen or a protective group compatible with the peptide bond, R 2 represents hydrogen, a protective group compatible with the peptide bond or a cation derived from an organic or inorganic base; pharmaceutically acceptable salts and diastereomers thereof. The compounds of the invention are useful for inhibiting the effect of the angiotensin-converting enzyme and they can be used in therapy as blood pressure reducing agents and for the treatment of cardiac failure and glaucoma.
摘要:
The present invention relates to a compound of formula (I) wherein
R' represents methyl or a group of the formula R 3 -NH-/CH 2 ) 4 - wherein R 3 is hydrogen or a protective group compatible with the peptide bond, R 2 represents hydrogen, a protective group compatible with the peptide bond or a cation derived from an organic or inorganic base; pharmaceutically acceptable salts and diastereomers thereof.
The compounds of the invention are useful for inhibiting the effect of the angiotensin-converting enzyme and they can be used in therapy as blood pressure reducing agents and for the treatment of cardiac failure and glaucoma.